241 related articles for article (PubMed ID: 310884)
1. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
Maddison PJ; Mogavero H; Reichlin M
J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of ribonucleoprotein antibody.
Rasmussen EK; Ullman S; Høier-Madsen M; Sørensen SF; Halberg P
Arch Dermatol; 1987 May; 123(5):601-5. PubMed ID: 3495241
[TBL] [Abstract][Full Text] [Related]
3. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
[TBL] [Abstract][Full Text] [Related]
4. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
[TBL] [Abstract][Full Text] [Related]
5. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
Appelboom T; Kahn MF; Peltier AP; de SEZE S
Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
[No Abstract] [Full Text] [Related]
6. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients.
Farber SJ; Bole GG
Arch Intern Med; 1976 Apr; 136(4):425-31. PubMed ID: 1083722
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of screening for antibody to ribonucleoprotein.
Small P; Barrett D; Champlin E
Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
[TBL] [Abstract][Full Text] [Related]
9. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
Uchida K; Kondo H; Kashiwazaki S
Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
[No Abstract] [Full Text] [Related]
10. Antibodies to ribosomal ribonucleoprotein. Prevalence in systemic rheumatic diseases and partial characterization of the antigen.
Cortés JJ; Mendoza F; Reyes PA
J Rheumatol; 1987 Aug; 14(4):727-31. PubMed ID: 3118019
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
Habets WJ; de Rooij DJ; Salden MH; Verhagen AP; van Eekelen CA; van de Putte LB; van Venrooij WJ
Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106
[TBL] [Abstract][Full Text] [Related]
12. Free serum ribonucleoprotein in mixed connective tissue disease and other connective tissue diseases.
Fishbein E; Ramos-Niembro F; Alarcon-Segovia D
J Rheumatol; 1978; 5(4):384-90. PubMed ID: 310882
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
Margaux J; Hayem G; Palazzo E; Chazerain P; De Bandt M; Haim T; Kahn MF; Meyer O
Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical and serologic markers in systemic lupus erythematosus and overlap syndrome: a review of 247 patients.
Ginsburg WW; Conn DL; Bunch TW; McDuffie FC
J Rheumatol; 1983 Apr; 10(2):235-41. PubMed ID: 6864677
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics of patients with nuclear antiribonucleoprotein antibodies. Evidence of circulating immunocomplexes in mixed connective tissue disease].
Rodríguez-Valverde V; Orte Martínez J; Sampedro Alvarez J; Peña Sagredo JL; Sánchez Andrada S
Med Clin (Barc); 1982 Jun; 79(1):9-15. PubMed ID: 7121111
[No Abstract] [Full Text] [Related]
16. Identification of specific antibodies to extractable nuclear antigens by passive immunodiffusion.
Kozin F; Fowler M
Am J Clin Pathol; 1979 Apr; 71(4):437-40. PubMed ID: 108995
[TBL] [Abstract][Full Text] [Related]
17. Raynaud's phenomenon and initially seronegative mixed connective tissue disease.
Ellman MH; Pachman L; Medof ME
J Rheumatol; 1981; 8(4):632-4. PubMed ID: 6975377
[TBL] [Abstract][Full Text] [Related]
18. [Sharp's syndrome: a new entity amongst the connective tissue diseases?].
Kahn MF; Peltier AP; Appelboom T
Nouv Presse Med; 1975 Jun; 4(25):1863-5. PubMed ID: 1080278
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and course in patients with high titer anti-RNP antibodies.
Lemmer JP; Curry NH; Mallory JH; Waller MV
J Rheumatol; 1982; 9(4):536-42. PubMed ID: 6982334
[TBL] [Abstract][Full Text] [Related]
20. Mixed connective tissue disease.
Prystowsky SD
West J Med; 1980 Apr; 132(4):288-93. PubMed ID: 7385833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
